Novavax’s Latecomer COVID-19 Vaccine Impresses With 90% Efficacy Result

Role As Booster Could Be Key

 
• By Andrew McConaghie
  
Novavax flag
The readout brings Novavax one step closer to its first ever product launch, and validation of its nanoparticle vaccine platform. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip